49 filings
Page 2 of 3
8-K
odts3shsl gzoxy
14 Nov 22
Gelesis Reports Third Quarter 2022 Results
8:56am
8-K
qzhy7bcve48r9b y66eh
4 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:02pm
8-K
2x1fs0xyhpmimj
3 Oct 22
Departure of Directors or Certain Officers
8:41am
8-K
slj92
15 Aug 22
Gelesis Reports Second Quarter 2022 Results
7:01am
8-K
7notg9iammv29 cab
12 Aug 22
Entry into a Material Definitive Agreement
4:02pm
8-K
whvbg2sm azjjy11cxm
10 Aug 22
Entry into a Material Definitive Agreement
4:48pm
8-K
rm7c83akka7g5 oeh
29 Jul 22
Entry into a Material Definitive Agreement
4:01pm
8-K
y1n64ezj3cvp
21 Jun 22
Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million
6:30am
8-K
vji046v iz
12 May 22
Results of Operations and Financial Condition
4:01pm
8-K
i6jfo192
10 May 22
Changes in Registrant's Certifying Accountant
4:39pm
8-K/A
r0bzsvg78z
1 Apr 22
Financial Statements and Exhibits
5:08pm
8-K/A
n1ysm1t94x945 ft93
24 Mar 22
Financial Statements and Exhibits
4:08pm
8-K
8ocuc2q5xgl5vksoci7
24 Mar 22
Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook
4:06pm
8-K
ct22wa76ov2i9p
16 Mar 22
New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch
6:31am
8-K
lpro85fs
31 Jan 22
Other Events
6:48am
8-K
bk3kzf sh
20 Jan 22
Proceeds from this transaction will be used to further support the national launch of Plenity
5:24pm
8-K
swso42k4qi8z822y eh
12 Jan 22
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
0p4s49g a1lhz
10 Jan 22
Other Events
6:25am
8-K
ozme881hg tqp
3 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
gwcpnadcece00fxvsmtn
13 Dec 21
Departure of Directors or Certain Officers
9:49pm